Pressure for over-the-counter (OTC) sales of Sensor Pad:
This article was originally published in Clinica
Nevada Congresswoman Barbara Vucanovich is trying to force the FDA to allow over-the-counter sales of Inventive Products' Sensor Pad breast self-examination device. If she succeeds, this will be the first time Congress has ever ordered approval in any status of a medical device. After years of controversy, the FDA approved the device several months ago (see Clinica No 687, p 16) - but has refused to allow non-prescription marketing of the silicone-filled device. Ms Vucanovich's legislation has not been assigned to any committee and action this year is unlikely.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.